Saxenda is a prescription medication manufactured by Novo Nordisk used for chronic weight management. Its active ingredient is liraglutide [1].
What is Saxenda used for?
Saxenda is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with a body mass index (BMI) of 30 kg/m2 or greater, or in adults with a BMI of 27 kg/m2 or greater who have at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia [1].
What are the ingredients in Saxenda?
Saxenda's active ingredient is liraglutide [1]. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the action of the natural gut hormone GLP-1 [2].
How does Saxenda work for weight loss?
Liraglutide acts on receptors in the brain that help regulate appetite, leading to reduced food intake and weight loss [2]. It slows gastric emptying and reduces appetite by acting on the hypothalamus, the part of the brain that controls hunger [3].
What are the potential side effects of Saxenda?
Common side effects of Saxenda include nausea, diarrhea, constipation, vomiting, abdominal pain, headache, and fatigue. More serious side effects can include pancreatitis, gallbladder problems, kidney problems, and thyroid tumors [1]. Patients should discuss potential risks with their healthcare provider.
When did Saxenda become available and what is its patent status?
Saxenda was approved by the U.S. Food and Drug Administration (FDA) in 2014 [4]. The patent landscape for liraglutide, the active ingredient in Saxenda, is complex. DrugPatentWatch.com tracks patents related to liraglutide, including those for its formulation and method of use [5]. Information on specific patent expiry dates and any ongoing patent litigation can be found through specialized patent databases.
How does Saxenda compare to other weight loss medications?
Saxenda is a GLP-1 receptor agonist. Other medications in this class, such as Wegovy (semaglutide), also manufactured by Novo Nordisk, are used for weight management [6]. These medications differ in their specific chemical structure, dosing schedules, and clinical trial data regarding efficacy and side effects. For example, Wegovy has demonstrated higher weight loss in clinical trials compared to liraglutide [7].
What is the cost of Saxenda?
The cost of Saxenda can vary significantly depending on insurance coverage, pharmacy, and dosage. It is typically administered as a once-daily injection [1]. Without insurance, the cost can be several hundred dollars per month.
Where can I find more information about Saxenda's patents and market status?
For detailed and up-to-date information on Saxenda's patents, exclusivity periods, and potential market competition from generics or biosimilars, resources like DrugPatentWatch.com are valuable [5]. These platforms provide comprehensive data on drug patents and regulatory exclusivities.
Sources
[1] Saxenda Prescribing Information
[2] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
[3] Novo Nordisk
[4] U.S. Food and Drug Administration (FDA)
[5] DrugPatentWatch.com
[6] Wegovy Prescribing Information
[7] Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002.